Market revenue in 2022 | USD 181.8 million |
Market revenue in 2030 | USD 416.3 million |
Growth rate | 10.9% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 22.22% in 2024. Horizon Databook has segmented the France biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The medical devices industry in France is highly regulated. The stringent directives laid by the European Commission regarding the use of premium-grade biopharma plastics for manufacturing medical devices can significantly impact the growth of biopharma plastics market in France.
The demand for biopharma plastics in the country is expected to be driven by the increasing use of PP, PE, PET, and ABS as raw materials for producing various biopharma plastic-based medical products such as valves, containers, and syringes.
Biopharma plastics market in France is expected to witness increased adoption of polypropylene for developing medical products used in internal and external applications, including implants, containers, and connectors.
Horizon Databook provides a detailed overview of country-level data and insights on the France biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into France biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account